Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T 1 /T 2 dual-weighted MRI and synergistic tumor diagnosis

A new class of hybrid lanthanide nanoparticles has been demonstrated as synergistic contrast agents in T 1 / T 2 dual-weighted MRI and imaging-directed tumor diagnosis.